Free Trial

Monogram Orthopaedics (NASDAQ:MGRM) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS

Monogram Orthopaedics logo with Medical background

Key Points

  • Monogram Orthopaedics reported a quarterly loss of ($0.16) EPS, missing analysts' estimates by ($0.05).
  • The company's stock opened at $5.33 and experienced a slight decline of 0.4% following the earnings announcement.
  • Jane Street Group LLC increased its stake in Monogram Orthopaedics by 83.0%, acquiring additional shares during the first quarter.
  • MarketBeat previews the top five stocks to own by October 1st.

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) posted its quarterly earnings results on Friday, August 15th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.05), Zacks reports.

Monogram Orthopaedics Stock Performance

Shares of MGRM remained flat at $5.46 during mid-day trading on Friday. The stock had a trading volume of 56,349 shares, compared to its average volume of 411,030. The stock has a market cap of $221.84 million, a P/E ratio of -10.92 and a beta of 0.69. Monogram Orthopaedics has a twelve month low of $1.92 and a twelve month high of $6.02. The stock has a 50-day simple moving average of $4.46 and a 200-day simple moving average of $3.27.

Institutional Trading of Monogram Orthopaedics

A hedge fund recently raised its stake in Monogram Orthopaedics stock. Jane Street Group LLC raised its position in shares of Monogram Orthopaedics Inc. (NASDAQ:MGRM - Free Report) by 83.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,426 shares of the company's stock after acquiring an additional 8,810 shares during the period. Jane Street Group LLC owned approximately 0.06% of Monogram Orthopaedics worth $57,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 0.45% of the company's stock.

About Monogram Orthopaedics

(Get Free Report)

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.

Featured Stories

Earnings History for Monogram Orthopaedics (NASDAQ:MGRM)

Should You Invest $1,000 in Monogram Orthopaedics Right Now?

Before you consider Monogram Orthopaedics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Monogram Orthopaedics wasn't on the list.

While Monogram Orthopaedics currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.